ANNOUNCEMENT

MedCity CONVERGE July 9-10 in Philly gathers payers, providers, medtech, pharma, digital health, policymakers & more.

Hirschler, Ben

Follow Hirschler, Ben: Website |


AstraZeneca needs new new products as others lose patent protection, accelerates drug pipeline

AstraZeneca needs new new products as others lose patent protection, accelerates drug pipeline

May 16, 2013 6:10 am by | 0 Comments

LONDON (Reuters) - AstraZeneca has enrolled the first patient into a final-stage clinical trial of a new drug for a rare type of leukemia as the group's new CEO delivers ... Read more

Big drugmakers think small with nanomedicine deals

Big drugmakers think small with nanomedicine deals

May 3, 2013 6:03 am by | 0 Comments

LONDON (Reuters) - Is nanomedicine the next big thing? A growing number of top drug companies seem to think so.The ability to encapsulate potent drugs in tiny particles measuring billionths ... Read more


Court stops EU regulator from releasing drug company data

Court stops EU regulator from releasing drug company data

April 30, 2013 8:30 am by | 0 Comments

LONDON (Reuters) - Europe's medicines regulator has been stopped from releasing clinical trial data about drugs made by AbbVie and Intermune, following a court ruling favoring the two U.S. companies.The ... Read more

Big brain projects highlight drug research gaps

Big brain projects highlight drug research gaps

April 11, 2013 7:25 am by | 0 Comments

LONDON (Reuters) - Governments on both sides of the Atlantic are placing big new bets on the future of brain science, just as much of the pharmaceutical industry retreats from ... Read more

Big Pharma down, not out, after Indian patent blow

Big Pharma down, not out, after Indian patent blow

April 2, 2013 10:53 am by | 0 Comments

LONDON/MUMBAI (Reuters) - Stung by a landmark patent defeat, Western drugmakers will be wary about launching new products in India, but they cannot afford to quit a country tipped to ... Read more

New vaccine for foot-and-mouth disease made totally from synthetic protein

New vaccine for foot-and-mouth disease made totally from synthetic protein

March 27, 2013 6:03 pm by | 0 Comments

LONDON (Reuters) - British scientists have developed a new vaccine against foot-and-mouth disease that is safer and easier to manufacture, an advance they believe should greatly increase production capacity and ... Read more

Experts: European financial crisis has direct impact on healthcare

Experts: European financial crisis has direct impact on healthcare

March 26, 2013 8:09 pm by | 0 Comments

LONDON (Reuters) - Europe's financial crisis is costing lives, with suicides and infectious diseases on the rise, yet politicians are not addressing the problem, health experts said on Wednesday. Deep ... Read more


GlaxoSmithKline boss says new drugs can be cheaper

GlaxoSmithKline boss says new drugs can be cheaper

March 14, 2013 11:15 am by | 0 Comments

LONDON (Reuters) - The pharmaceutical industry should be able to charge less for new drugs in future by passing on efficiencies in research and development to its customers, according to ... Read more

Industry and EU clash over medical devices regulation

Industry and EU clash over medical devices regulation

February 20, 2013 9:16 am by | 0 Comments

LONDON (Reuters) - One year on from a breast implant scandal that shook confidence in Europe's light-touch system for regulating medical devices, lawmakers and manufacturers are at loggerheads on ways ... Read more

Star-gazing software offers faster way to analyze breast cancer samples

Star-gazing software offers faster way to analyze breast cancer samples

February 19, 2013 7:01 pm by | 0 Comments

LONDON (Reuters) - In an unlikely tie-up, astronomers and cancer researchers have joined forces to study breast tumors using image analysis software originally developed to explore the distant stars.The automated ... Read more

Novartis CEO tempers talk of Roche stake sale

Novartis CEO tempers talk of Roche stake sale

January 25, 2013 3:30 am by | 0 Comments

DAVOS, Switzerland (Reuters) - Novartis Chief Executive Joe Jimenez played down talk that it was looking to sell its one-third voting stake in crosstown rival Roche, and certainly not at ... Read more

FDA approved 39 new drugs in 2012, hits a 16-year high

FDA approved 39 new drugs in 2012, hits a 16-year high

December 31, 2012 3:50 pm by | 0 Comments

LONDON/NEW YORK (Reuters) - U.S. regulators approved 39 new drugs in 2012, the most in 16 years, suggesting that pharmaceutical makers are poised for growth after losing billions of dollars ... Read more

Number of new drugs picks up in Europe and U.S.

Number of new drugs picks up in Europe and U.S.

December 18, 2012 12:20 pm by | 0 Comments

LONDON (Reuters) - The number of new medicines approved or pending approval is on the rise on both sides of the Atlantic, painting an encouraging picture for the global drugs ... Read more

Vivalis to buy Intercell in European biotech merger

Vivalis to buy Intercell in European biotech merger

December 17, 2012 8:43 am by | 0 Comments

LONDON/PARIS (Reuters) - France's Vivalis and Austrian vaccine specialist Intercell are linking up in a rare cross-border deal that shows the need for Europe's fledgling biotech companies to grow in ... Read more

Roche manuevers to cut off boycott of flu drug Tamiflu

Roche manuevers to cut off boycott of flu drug Tamiflu

November 22, 2012 11:04 am by | 0 Comments

LONDON (Reuters) - Roche has offered an olive branch to scientific critics in a bid to end a bitter row over blockbuster flu drug Tamiflu that has led to calls ... Read more